Depolarization-induced rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain synaptosomes

Journal of Biochemistry

Volumn 141, Issue 5, 2007, Pages 687-697

  Oka, Saori ^a   Arai, Shunsuke ^a   Waku, Keizo ^a   Tokumura, Akira ^b   Sugiura, Takayuki ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

2 arachidonoylglycerol; Anandamide; Cannabinoid; Monoacylglycerol; Synaptosomes

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CALCIMYCIN; CANNABINOID RECEPTOR; DIACYLGLYCEROL; GLUTAMIC ACID; MONOACYLGLYCEROL; PHOSPHOLIPASE C; RIMONABANT;

ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; DEPOLARIZATION; MALE; NONHUMAN; PHOSPHOLIPID METABOLISM; PROTEIN SECRETION; RAT; STATISTICAL SIGNIFICANCE; SYNAPTIC MEMBRANE;

ANIMALS; ARACHIDONIC ACIDS; BORNANES; BRAIN; CALCIMYCIN; CALCIUM CHANNEL BLOCKERS; DIGLYCERIDES; ESTRENES; FATTY ACIDS; GLYCERIDES; MALE; MEMBRANE POTENTIALS; NEUROMUSCULAR DEPOLARIZING AGENTS; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; PYRROLIDINONES; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; SYNAPTOSOMES;

RATTUS;

EID: 34347365313     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/jb/mvm070     Document Type: Article

References (48)

1. Pertwee, R.G. (2004) Pharmacological actions of cannabinoids, in Cannabinoids (Pertwee, R.G., ed.) pp. 1-51, Springer, Berlin
2. Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., and Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949
3. Di Marzo, V., De Petrocellis, L., and Bisogno, T. (2004) The biosynthesis, fate and pharmacological properties of endocannabinoids, in Cannabinoids (Pertwee, R.G., ed.) pp. 147-185, Springer, Berlin
4. Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., and Waku, K. (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215, 89-97
5. Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N.E., Schatz, A.R., Gopher, A., Almog, S., Martin, B.R., Compton, D.R., Pertwee, R.G., Griffin, G., Bayewitch, M., Barg, J., and Vogel, Z. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50, 83-90
6. Sugiura, T. and Waku, K. (2000) 2-Arachidonoylglycerol and the cannabinoid receptors. Chem. Phys. Lipids 108, 89-106
7. Sugiura, T., Kobayashi, Y., Oka, S., and Waku, K. (2002) Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostaglandins Leukot. Essent. Fatty Acids 66, 173-192
8. 2+ in neuroblastoma x glioma hybrid NG108-15 cells. Biochem. Biophys. Res. Commun. 229, 58-64
9. 2+ transient in NG108-15 cells. J. Biochem. 122, 890-895
10. Sugiura, T., Kodaka, T., Nakane, S., Miyashita, T., Kondo, S., Suhara, Y., Takayama, H., Waku, K., Seki, C., Baba, N., and Ishima, Y. (1999) Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds. J. Biol. Chem. 274, 2794-2801
11. Sugiura, T., Kondo, S., Kishimoto, S., Miyashita, T., Nakane, S., Kodaka, T., Suhara, Y., Takayama, H., and Waku, K. (2000) Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor. J. Biol. Chem. 275, 605-612
12. Hillard, C.J. (2000) Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol. Prostaglandins Other Lipid Mediat. 61, 3-18
13. Gonsiorek, W., Lunn, C., Fan, X., Narula, S., Lundell, D., and Hipkin, R.W. (2000) Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. Mol. Pharmacol. 57, 1045-1050
14. Savinainen, J.R., Jarvinen, T., Laine, K., and Laitinen, J.T. (2001) Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes. Br. J. Pharmacol. 134, 664-672
15. Sugiura, T., Kodaka, T., Kondo, S., Tonegawa, T., Nakane, S., Kishimoto, S., Yamashita, A., and Waku, K. (1997) Inhibition by 2-arachidonoylglycerol, a novel type of possible neuromodulator, of the depolarization-induced increase in intracellular free calcium in neuroblastoma x glioma hybrid NG108-15 cells. Biochem. Biophys. Res. Commun. 233, 207-210
16. Oz, M., Tchugunova, Y., and Dinc, M. (2004) Differential effects of endogenous and synthetic cannabinoids on voltage-dependent calcium fluxes in rabbit T-tubule membranes: comparison with fatty acids. Eur. J. Pharmacol. 502, 47-58
17. Guo, J. and Ikeda, S.R. (2004) Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. Mol. Pharmacol. 65, 665-674
18. Stella, N., Schweitzer, P., and Piomelli, D. (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature 388, 773-778
19. Ameri, A. and Simmet, T. (2000) Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices. Naunyn Schmiedebergs Arch. Pharmacol. 361, 265-272
20. Bisogno, T., Sepe, N., Melck, D., Maurelli, S., De Petrocellis, L., and Di Marzo, V. (1997) Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells. Biochem. J. 322, 671-677
21. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C., and Bonner, T.I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564
22. Herkenham, M. (1995) Localization of cannabinoid receptors in brain and periphery, in Cannabinoid Receptors (Pertwee, R.G., ed.) pp. 145-166, Academic Press, London
23. Nicholls, D.G. (1978) Calcium transport and porton electrochemical potential gradient in mitochondria from guinea-pig cerebral cortex and rat heart. Biochem. J. 170, 511-522
24. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275
25. Bligh, E.G. and Dyer, W.J. (1959) A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917
26. Oka, S., Yanagimoto, S., Ikeda, S., Gokoh, M., Kishimoto, S., Waku, K., Ishima, Y., and Sugiura, T. (2005) Evidence for the involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation in mouse ear. J. Biol. Chem. 280, 18488-18497
27. Di Marzo, V., Melck, D., Bisogno, T., and De Petrocellis, L. (1998) Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci 21, 521-528; Erratum (1999) Trends Neurosci. 22, 80.
28. Schlicker, E. and Kathmann, M. (2001) Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol. Sci. 22, 565-572
29. 2+-dependent and -independent mechanisms. FEBS Lett. 429, 152-156
30. Sugiura, T., Yoshinaga, N., Kondo, S., Waku, K., and Ishima, Y. (2000) Generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in picrotoxinin-administered rat brain. Biochem. Biophys. Res. Commun. 271, 654-658
31. Sugiura, T., Yoshinaga, N., and Waku, K. (2001) Rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain after decapitation. Neurosci. Lett. 297, 175-178
32. Sugiura, T., Kondo, S., Kodaka, T., Nakane, S., Yamashita, A., Kishimoto, S., Waku, K., and Ishima, Y. (1998) Biosynthesis and actions of anandamide and 2-arachidonoylglycerol: two endogenous cannabimimetic molecules, in Essential Fatty Acids and Eicosanoids (Riemesma, R.A., Armstrong, R., Kelly, W., and Wilson, R., eds) pp. 380-384, AOCS Press, Champaign
33. Sugiura, T., Kodaka, T., Nakane, S., Kishimoto, S., Kondo, S., and Waku, K. (1998) Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: is 2-arachidonoylglycerol a possible vasomodulator? Biochem. Biophys. Res. Commun. 243, 838-843
34. Stella, N. and Piomelli, D. (2001) Receptor-dependent formation of endogenous cannabinoids in cortical neurons. Eur. J. Pharmacol. 425, 189-196
35. Ohno-Shosaku, T., Maejima, T., and Kano, M. (2001) Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29, 729-738
36. Wilson, R.I. and Nicoll, R.A. (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410, 588-592
37. Kreitzer, A.C. and Regehr, W.G. (2001) Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 29, 717-727
38. Wilson, R.I. and Nicoll, R.A. (2002) Endocannabinoid signaling in the brain. Science 296, 678-682
39. Diana, M.A. and Marty, A. (2004) Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE). Br. J. Pharmacol. 142, 9-19
40. Howlett, A.C., Breivogel, C.S., Childers, S.R., Deadwyler, S.A., Hampson, R.E., and Porrino, L.J. (2004) Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 47, (Suppl 1), 345-358
41. Vaughan, C.W. and Christie, M.J. (2005) Retrograde signalling by endocannabinoids. Handb. Exp. Pharmacol. 168, 367-383
42. Oka, S., Ishima, Y., Waku, K., and Sugiura, T. (2006) Endocannabinoids as retrograde messengers in the synaptic transmission, in Endocannabinoids: The Brain and Body's Marijuana and Beyond (Onaivi, E, Sugiura, T., and Di Marzo, V., eds) pp. 133-149, Taylor and Francis, London
43. Melis, M., Perra, S., Muntoni, A.L., Pillolla, G., Lutz, B., Marsicano, G., Di Marzo, V., Gessa, G.L., and Pistis, M. (2004) Prefrontal cortex stimulation induces 2-arachidonoylglycerol-mediated suppression of excitation in dopamine neurons. J. Neurosci. 24, 10707-10715
44. Galante, M. and Diana, M.A. (2004) Group I metabotropic glutamate receptors inhibit GABA release at interneuron-Purkinje cell synapses through endocannabinoid production. J. Neurosci. 24, 4865-4874
45. 2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cβ4 signaling cascade in the cerebellum. J. Neurosci. 25, 6826-6835
46. Jung, K.M., Mangieri, R., Stapleton, C., Kim, J., Fegley, D., Wallace, M., Mackie, K., and Piomelli, D. (2005) Stimulation of endocannabinoid formation in brain slice cultu through activation of group I metabotropic glutamate receptors. Mol. Pharmacol. 68, 1196-1202
47. Edwards, D.A., Kim, J., and Alger, B.E. (2006) Multiple mechanisms of endocannabinoid response initiation in hippocampus. J. Neurophysiol. 95, 67-75
48. Safo, P.K. and Regehr, W.G. (2005) Endocannabinoids control the induction of cerebellar LTD. Neuron 48, 647-659